Copyright Reports & Markets. All rights reserved.

Global Hematology Controls Market Research Report 2023

Request for Sample of this report
Buy now

1 Hematology Controls Market Overview

  • 1.1 Product Overview and Scope of Hematology Controls
  • 1.2 Hematology Controls Segment by Type
    • 1.2.1 Global Hematology Controls Market Value Comparison by Type (2023-2029)
    • 1.2.2 3-Part Hematology Controls
    • 1.2.3 5-Part Hematology Controls
    • 1.2.4 Others
  • 1.3 Hematology Controls Segment by Application
    • 1.3.1 Global Hematology Controls Market Value by Application: (2023-2029)
    • 1.3.2 Hospital
    • 1.3.3 Independent Lab
    • 1.3.4 Others
  • 1.4 Global Hematology Controls Market Size Estimates and Forecasts
    • 1.4.1 Global Hematology Controls Revenue 2018-2029
    • 1.4.2 Global Hematology Controls Sales 2018-2029
    • 1.4.3 Global Hematology Controls Market Average Price (2018-2029)
  • 1.5 Assumptions and Limitations

2 Hematology Controls Market Competition by Manufacturers

  • 2.1 Global Hematology Controls Sales Market Share by Manufacturers (2018-2023)
  • 2.2 Global Hematology Controls Revenue Market Share by Manufacturers (2018-2023)
  • 2.3 Global Hematology Controls Average Price by Manufacturers (2018-2023)
  • 2.4 Global Hematology Controls Industry Ranking 2021 VS 2022 VS 2023
  • 2.5 Global Key Manufacturers of Hematology Controls, Manufacturing Sites & Headquarters
  • 2.6 Global Key Manufacturers of Hematology Controls, Product Type & Application
  • 2.7 Hematology Controls Market Competitive Situation and Trends
    • 2.7.1 Hematology Controls Market Concentration Rate
    • 2.7.2 The Global Top 5 and Top 10 Largest Hematology Controls Players Market Share by Revenue
    • 2.7.3 Global Hematology Controls Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
  • 2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3 Hematology Controls Retrospective Market Scenario by Region

  • 3.1 Global Hematology Controls Market Size by Region: 2018 Versus 2022 Versus 2029
  • 3.2 Global Hematology Controls Global Hematology Controls Sales by Region: 2018-2029
    • 3.2.1 Global Hematology Controls Sales by Region: 2018-2023
    • 3.2.2 Global Hematology Controls Sales by Region: 2024-2029
  • 3.3 Global Hematology Controls Global Hematology Controls Revenue by Region: 2018-2029
    • 3.3.1 Global Hematology Controls Revenue by Region: 2018-2023
    • 3.3.2 Global Hematology Controls Revenue by Region: 2024-2029
  • 3.4 North America Hematology Controls Market Facts & Figures by Country
    • 3.4.1 North America Hematology Controls Market Size by Country: 2018 VS 2022 VS 2029
    • 3.4.2 North America Hematology Controls Sales by Country (2018-2029)
    • 3.4.3 North America Hematology Controls Revenue by Country (2018-2029)
    • 3.4.4 United States
    • 3.4.5 Canada
  • 3.5 Europe Hematology Controls Market Facts & Figures by Country
    • 3.5.1 Europe Hematology Controls Market Size by Country: 2018 VS 2022 VS 2029
    • 3.5.2 Europe Hematology Controls Sales by Country (2018-2029)
    • 3.5.3 Europe Hematology Controls Revenue by Country (2018-2029)
    • 3.5.4 Germany
    • 3.5.5 France
    • 3.5.6 U.K.
    • 3.5.7 Italy
    • 3.5.8 Russia
  • 3.6 Asia Pacific Hematology Controls Market Facts & Figures by Country
    • 3.6.1 Asia Pacific Hematology Controls Market Size by Country: 2018 VS 2022 VS 2029
    • 3.6.2 Asia Pacific Hematology Controls Sales by Country (2018-2029)
    • 3.6.3 Asia Pacific Hematology Controls Revenue by Country (2018-2029)
    • 3.6.4 China
    • 3.6.5 Japan
    • 3.6.6 South Korea
    • 3.6.7 India
    • 3.6.8 Australia
    • 3.6.9 China Taiwan
    • 3.6.10 Indonesia
    • 3.6.11 Thailand
    • 3.6.12 Malaysia
  • 3.7 Latin America Hematology Controls Market Facts & Figures by Country
    • 3.7.1 Latin America Hematology Controls Market Size by Country: 2018 VS 2022 VS 2029
    • 3.7.2 Latin America Hematology Controls Sales by Country (2018-2029)
    • 3.7.3 Latin America Hematology Controls Revenue by Country (2018-2029)
    • 3.7.4 Mexico
    • 3.7.5 Brazil
    • 3.7.6 Argentina
    • 3.7.7 Colombia
  • 3.8 Middle East and Africa Hematology Controls Market Facts & Figures by Country
    • 3.8.1 Middle East and Africa Hematology Controls Market Size by Country: 2018 VS 2022 VS 2029
    • 3.8.2 Middle East and Africa Hematology Controls Sales by Country (2018-2029)
    • 3.8.3 Middle East and Africa Hematology Controls Revenue by Country (2018-2029)
    • 3.8.4 Turkey
    • 3.8.5 Saudi Arabia
    • 3.8.6 UAE

4 Segment by Type

  • 4.1 Global Hematology Controls Sales by Type (2018-2029)
    • 4.1.1 Global Hematology Controls Sales by Type (2018-2023)
    • 4.1.2 Global Hematology Controls Sales by Type (2024-2029)
    • 4.1.3 Global Hematology Controls Sales Market Share by Type (2018-2029)
  • 4.2 Global Hematology Controls Revenue by Type (2018-2029)
    • 4.2.1 Global Hematology Controls Revenue by Type (2018-2023)
    • 4.2.2 Global Hematology Controls Revenue by Type (2024-2029)
    • 4.2.3 Global Hematology Controls Revenue Market Share by Type (2018-2029)
  • 4.3 Global Hematology Controls Price by Type (2018-2029)

5 Segment by Application

  • 5.1 Global Hematology Controls Sales by Application (2018-2029)
    • 5.1.1 Global Hematology Controls Sales by Application (2018-2023)
    • 5.1.2 Global Hematology Controls Sales by Application (2024-2029)
    • 5.1.3 Global Hematology Controls Sales Market Share by Application (2018-2029)
  • 5.2 Global Hematology Controls Revenue by Application (2018-2029)
    • 5.2.1 Global Hematology Controls Revenue by Application (2018-2023)
    • 5.2.2 Global Hematology Controls Revenue by Application (2024-2029)
    • 5.2.3 Global Hematology Controls Revenue Market Share by Application (2018-2029)
  • 5.3 Global Hematology Controls Price by Application (2018-2029)

6 Key Companies Profiled

  • 6.1 Sysmex
    • 6.1.1 Sysmex Corporation Information
    • 6.1.2 Sysmex Description and Business Overview
    • 6.1.3 Sysmex Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
    • 6.1.4 Sysmex Hematology Controls Product Portfolio
    • 6.1.5 Sysmex Recent Developments/Updates
  • 6.2 Danaher
    • 6.2.1 Danaher Corporation Information
    • 6.2.2 Danaher Description and Business Overview
    • 6.2.3 Danaher Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
    • 6.2.4 Danaher Hematology Controls Product Portfolio
    • 6.2.5 Danaher Recent Developments/Updates
  • 6.3 Bio-Rad
    • 6.3.1 Bio-Rad Corporation Information
    • 6.3.2 Bio-Rad Description and Business Overview
    • 6.3.3 Bio-Rad Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
    • 6.3.4 Bio-Rad Hematology Controls Product Portfolio
    • 6.3.5 Bio-Rad Recent Developments/Updates
  • 6.4 Mindray
    • 6.4.1 Mindray Corporation Information
    • 6.4.2 Mindray Description and Business Overview
    • 6.4.3 Mindray Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
    • 6.4.4 Mindray Hematology Controls Product Portfolio
    • 6.4.5 Mindray Recent Developments/Updates
  • 6.5 Abbott
    • 6.5.1 Abbott Corporation Information
    • 6.5.2 Abbott Description and Business Overview
    • 6.5.3 Abbott Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
    • 6.5.4 Abbott Hematology Controls Product Portfolio
    • 6.5.5 Abbott Recent Developments/Updates
  • 6.6 Horiba
    • 6.6.1 Horiba Corporation Information
    • 6.6.2 Horiba Description and Business Overview
    • 6.6.3 Horiba Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
    • 6.6.4 Horiba Hematology Controls Product Portfolio
    • 6.6.5 Horiba Recent Developments/Updates
  • 6.7 Boule
    • 6.6.1 Boule Corporation Information
    • 6.6.2 Boule Description and Business Overview
    • 6.6.3 Boule Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
    • 6.4.4 Boule Hematology Controls Product Portfolio
    • 6.7.5 Boule Recent Developments/Updates
  • 6.8 Diatron
    • 6.8.1 Diatron Corporation Information
    • 6.8.2 Diatron Description and Business Overview
    • 6.8.3 Diatron Hematology Controls Sales, Revenue and Gross Margin (2018-2023)
    • 6.8.4 Diatron Hematology Controls Product Portfolio
    • 6.8.5 Diatron Recent Developments/Updates

7 Industry Chain and Sales Channels Analysis

  • 7.1 Hematology Controls Industry Chain Analysis
  • 7.2 Hematology Controls Key Raw Materials
    • 7.2.1 Key Raw Materials
    • 7.2.2 Raw Materials Key Suppliers
  • 7.3 Hematology Controls Production Mode & Process
  • 7.4 Hematology Controls Sales and Marketing
    • 7.4.1 Hematology Controls Sales Channels
    • 7.4.2 Hematology Controls Distributors
  • 7.5 Hematology Controls Customers

8 Hematology Controls Market Dynamics

  • 8.1 Hematology Controls Industry Trends
  • 8.2 Hematology Controls Market Drivers
  • 8.3 Hematology Controls Market Challenges
  • 8.4 Hematology Controls Market Restraints

9 Research Finding and Conclusion

    10 Methodology and Data Source

    • 10.1 Methodology/Research Approach
      • 10.1.1 Research Programs/Design
      • 10.1.2 Market Size Estimation
      • 10.1.3 Market Breakdown and Data Triangulation
    • 10.2 Data Source
      • 10.2.1 Secondary Sources
      • 10.2.2 Primary Sources
    • 10.3 Author List

    Hematology controls are used to assess the precision of instruments such as hematology analyzers, thereby ensuring valid patient results and fulfilling accreditation requirements. The controls are commonly found in the clinical diagnostics laboratory.

    According to QYResearch’s new survey, global Hematology Controls market is projected to reach US$ 518.6 million in 2029, increasing from US$ 323.3 million in 2022, with the CAGR of 6.9% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Hematology Controls market research.

    Global key players of Hematology Controls include Sysmex, Danaher, etc. Global top 3 companies hold a share about 70%. Asia Pacific is the largest market, with a share about 40%, followed by Europe and North America with the share about 25% and 20%. In terms of product, 3-Part is the largest segment, with a share over 60%. And in terms of application, the largest application is Hospital, with a share over 60%.

    Report Scope
    This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Hematology Controls market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

    By Company
    Sysmex
    Danaher
    Bio-Rad
    Mindray
    Abbott
    Horiba
    Boule
    Diatron

    Segment by Type
    3-Part Hematology Controls
    5-Part Hematology Controls
    Others

    Segment by Application
    Hospital
    Independent Lab
    Others

    Consumption by Region
    North America
    United States
    Canada
    Europe
    Germany
    France
    U.K.
    Italy
    Russia
    Asia-Pacific
    China
    Japan
    South Korea
    India
    Australia
    China Taiwan
    Indonesia
    Thailand
    Malaysia
    Latin America
    Mexico
    Brazil
    Argentina
    Colombia
    Middle East & Africa
    Turkey
    Saudi Arabia
    UAE

    The Hematology Controls report covers below items:
    Chapter 1: Product Basic Information (Definition, Type and Application)
    Chapter 2: Manufacturers’ Competition Patterns
    Chapter 3: Country Level Sales Analysis
    Chapter 4: Product Type Analysis
    Chapter 5: Product Application Analysis
    Chapter 6: Manufacturers’ Outline
    Chapter 7: Industry Chain, Market Channel and Customer Analysis
    Chapter 8: Market Opportunities and Challenges
    Chapter 9: Market Conclusions
    Chapter 10: Research Methodology and Data Source
    Buy now